This is a multi-center, randomized, double-blind, placebo-controlled, proof of concept study to assess the safety and tolerability of ANB20 in adult patients with severe eosinophilic asthma.
The purpose of this study will also assess the safety and tolerability of ANB020 in adult patients with severe eosinophilic asthma.